GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Remus Pharmaceuticals REMUS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

820.50

+2.50%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹6.20bn

FY2022FY2025

Net income

₹290.7m

FY2022FY2025

Free cash flow

₹30.1m

FY2022FY2025

Shareholders' equity

₹2.56bn

FY2022FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022
Revenue₹6.20bn₹2.12bn₹450.3m₹247.2m
Operating income₹438.2m₹269.1m₹100.9m₹39.2m
Net income₹290.7m₹215.4m₹85.0m₹33.9m
Diluted earnings per share24.6719.0010.412.87

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022
Total assets₹4.33bn₹2.57bn₹346.6m₹159.1m
Cash and short-term investments₹245.6m₹293.4m₹30.4m₹11.5m
Total liabilities₹1.77bn₹1.70bn₹155.3m₹94.8m
Debt₹229.8m₹115.5m₹79.4m₹1.9m
Shareholders' equity₹2.56bn₹868.6m₹191.4m₹64.3m
Shares outstanding12m11m8m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022
Cash from operations₹69.9m₹36.0m₹53.1m₹50.4m
Capital spending−₹39.8m−₹6.4m−₹27.3m−₹710,000
Free cash flow₹30.1m₹29.7m₹25.8m₹49.7m
Dividends paid−₹11.8m−₹5.9m——

Latest quarters

By quarter end

Mar 2025Sept 2024Mar 2024Sept 2023
Revenue₹3.48bn₹2.73bn₹1.83bn₹290.4m
Operating income₹236.9m₹201.3m₹180.7m₹88.5m
Net income₹150.6m₹140.1m₹158.9m₹56.5m
Diluted earnings per share12.7811.8913.485.18
Total assets₹4.33bn₹2.21bn₹2.57bn₹855.4m
Cash and short-term investments₹273.4m₹459.9m₹293.4m₹422.8m
Debt₹224.7m₹37.2m₹30.0m₹14.4m
Shareholders' equity₹2.56bn₹1.00bn₹868.6m₹714.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue192.8%——
Operating income123.7%——
Net income104.8%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings28.563.186.4
Price to sales1.36.416.3

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 14 Nov 2025.

FY2026FY2025FY2024
Paid in the year1.001.000.50
  • 2-for-1 split · 4 Jul 2025
  • 4-for-1 split · 6 Jun 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.